Non Federal Funding

Research in the following areas: Basic and Laboratory Sciences, Population Sciences, Outcomes Research, Clinical Sciences, Methodology Research, Drug/Protocol Development, Patient Safety, Education, Policy Research, or Health Services Research.

BSF seeks to provide seed grant funding to young and established investigators in order to generate the preliminary data required for successful follow-on funding available from major grant-making institutions such as the National Institutes of Health (NIH).

The Heart to Heart Grant now has two arms of eligibility for two different grants, Clinical and Community:

Clinical: projects that are traditional bench/clinical research. These projects may be from hospitals, universities/schools, or research programs. The Heart to Heart Clinical Grant is $100,000.
Community: projects more focused on community engagement, education, and programming as opposed to research. These proposals may come from hospitals, universities/schools, or community organizations. The Heart to Heart Community Grant is up to $25,000.

Capacity Building: Funds projects that build the capacity and skills of patients, caregivers and the broader healthcare community to engage in and with patient-centered CER and partner with researchers in meaningful ways throughout the research lifecycle. Projects may also strengthen researchers’ patient-centered CER engagement skills or help prior awardees broaden the impact of their capacity-building work.
Dissemination Initiative: Funds projects that help organizations and communities actively communicate relevant PCORI-funded research results to specific audiences. Projects should focus on active dissemination activities that increase awareness and knowledge of the PCORI-funded research results. The funding opportunity identifies the eligible sources of PCORI-funded research results that may be proposed as the basis for dissemination activities under this award.
Convening Support: Funds projects that enable patients, caregivers and the broader healthcare community to hold convenings and conferences to promote patient-centered CER, share patient-centered CER engagement methods, disseminate PCORI-funded research results or plan for future patient-centered CER.
Building Capacity for Small Organizations To Engage in Patient-Centered CER: Funds projects that build capacity and skills of small organizations to engage in patient-centered CER and reflect the unique perspectives and contributions that small organizations can bring to the patient-centered CER process. Awardees participate in a peer learning network in addition to carrying out their project activities.

Research should be basic directed in any area of the life sciences.

Award is for faculty investigators to explore an innovative concept in “translational” science that has applicability to improving human health. Examples could include fundamental research, diagnostic tests, biomarkers, biomedical engineering advances, and imaging advances. Collection of data for improved evidence-based medical guidance are of great interest.

The Career Development Award will support two-year grants in basic, translational, or clinical research studying any discipline involved in Marfan syndrome, Loeys-Dietz syndrome, Vascular Ehlers-Danlos syndrome, and other related conditions. This grant program is designed to support investigators early in their career to derive preliminary data in a key concept area that has high potential to lead to extended funding from NIH, EU, and other large research funding sources.

These fellowships are intended to cultivate interest in Huntington’s disease research by encouraging promising early career scientists.

Grants provide more experienced researchers with seed funding to enable them to collect the preliminary data needed to obtain major, long-term funding from other organizations, including the National Institutes of Health.

The prize recognizes significant and exciting work that has changed the way we think about multiple sclerosis. Only accomplishments directly related to multiple sclerosis will be considered; advances in other central nervous system inflammatory diseases will be considered only insofar as they advance the understanding of multiple sclerosis. While service to and leadership of the multiple sclerosis community will be considered, innovative research with lasting impact on the understanding of and/or treatment of multiple sclerosis is the primary criterion for selection. Recent and ongoing active research is a major consideration; the Dystel Prize is not meant to be a lifetime achievement award.

Funding will support projects aimed at:

Pre-Clinical: Identifying, validating and/or developing novel pharmacological and non-pharmacological interventions through pre-clinical development from early screening to pre-clinical characterization and testing.
Clinical: Progressing promising interventions with strong pre-clinical packages into/through initial clinical assessment exploring pharmacokinetics and pharmacodynamics, safety/tolerability, or early proof of biology and/or clinical efficacy. For novel targets, MJFF is particularly interested in de-risking programs by supporting early proof of concept in patients to gain insight into the therapeutic potential, including exploration of biomarker-based or clinical endpoint-based efficacy.

he Parkinson's Foundation Impact Awards support innovative projects from their inception, providing the necessary resources to maximize their impact on the Parkinson's community. The science underlying the Parkinson's Foundation Impact Award projects should be "outside the box" with the goal of bringing new light to the biology of Parkinson’s disease (PD), a new approach to PD research, or testing a truly novel therapeutic idea. Projects should be based on groundbreaking or unconventional ideas that are unlikely to be funded through more traditional funding mechanisms. Both established researchers and newcomers to PD research are encouraged to apply.

Research proposals from promising early-career scientists that will directly impact the understanding of Parkinson’s disease or its treatment.

The letter should clearly describe how the proposed research will uncover mechanisms of brain injury or diseases and how it will translate to diagnosis, prevention, treatment, or cure.

The foundation is currently interested in invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.

The foundation is currently interested in invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.

Impact Research Grant addresses gaps in high-acuity and critical care areas of clinical research. The grants will ensure the pipeline for research that is vital to AACN’s research translation resources, such as protocols and practice alerts.

The NCSBN Grant Program provides funding for scientific research projects that advance the science of nursing policy and regulation and build regulatory expertise worldwide. Research Priorities include, but are not limited to: Outcome studies related to nursing regulation; Nursing workforce; Substance use disorders in nursing; New technologies related to the profession;
Practice innovations/new models of care delivery
LPN, RN and APRN scope of practice; Impact of policy on nursing.

Qualified proposals must be relevant to high acuity and critical care nursing practice and address one or more of AACN’s research priority areas. Proposals should also link with AACN’s research vision and agenda. The grant may be used to fund research for an academic degree.

These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers.

To provide research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program.

The Leukemia & Lymphoma Society supports talented blood cancer researchers in the early phase of their careers through the Career Development Program. CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients.

The Young Investigator Award promotes and recognizes clinical and translational research that advances innovative ideas and concepts designed to improve health outcomes through advances in the delivery of cancer-related care.

The Clinical Investigator Award promotes patient-focused research conducted by surgical oncologists in clinical and translational science.

The bulk of the research funding has been awarded to early career professionals — individuals just beginning the long path to become physician-scientists. In most cases, this was their first funded research project. These individuals are crucial to advancing science as discovery continues to provide improved options and outcomes for those diagnosed with gynecologic cancer.

Solving the complex issues of glaucoma through well-conceived and executed scientific research focused on finding the causes and new treatments for the disease.

Research should address a mathematical or theoretical topic of fundamental scientific importance, where a significant, new development creates a novel area for exploration or provides a new direction for progress in an established field.

This grant is investigator-initiated and supports high-impact research projects aimed at addressing gaps in knowledge that impact the ability to provide optimal, patient-centered, cost-effective diagnosis and care for people with sleep disorders.

Advance the development of alternatives to animal testing in toxicological research.